Victory Capital Management Inc. Sells 51,093 Shares of DaVita Inc. (NYSE:DVA)

Victory Capital Management Inc. decreased its position in DaVita Inc. (NYSE:DVA - Free Report) by 56.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,263 shares of the company's stock after selling 51,093 shares during the quarter. Victory Capital Management Inc.'s holdings in DaVita were worth $6,436,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in DVA. Transcendent Capital Group LLC acquired a new stake in DaVita in the third quarter valued at about $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after buying an additional 78 shares during the period. Family Firm Inc. bought a new position in DaVita in the 2nd quarter valued at approximately $43,000. Versant Capital Management Inc boosted its position in DaVita by 90.6% during the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company's stock worth $45,000 after buying an additional 155 shares during the period. Finally, Friedenthal Financial bought a new stake in DaVita during the 2nd quarter worth approximately $48,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction on Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now directly owns 837,835 shares in the company, valued at $138,284,666.75. The trade was a 5.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Joel Ackerman sold 64,029 shares of the firm's stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the sale, the chief financial officer now owns 111,481 shares of the company's stock, valued at $17,286,243.86. This trade represents a 36.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 156,086 shares of company stock worth $24,807,161 over the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

DVA has been the topic of several analyst reports. Truist Financial boosted their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a research note on Monday, October 7th. Barclays upped their target price on DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a report on Thursday, October 31st. UBS Group boosted their price target on shares of DaVita from $169.00 to $175.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. Finally, Bank of America boosted their target price on shares of DaVita from $139.00 to $145.00 and gave the company an "underperform" rating in a report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $161.80.

DaVita Stock Up 0.8 %

DaVita stock traded up $1.37 during mid-day trading on Friday, reaching $165.51. The stock had a trading volume of 612,123 shares, compared to its average volume of 1,021,709. The firm has a market capitalization of $13.57 billion, a PE ratio of 17.85, a price-to-earnings-growth ratio of 0.93 and a beta of 0.89. DaVita Inc. has a fifty-two week low of $98.26 and a fifty-two week high of $168.50. The stock's 50-day simple moving average is $158.31 and its 200-day simple moving average is $148.36. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business posted $2.85 EPS. On average, sell-side analysts forecast that DaVita Inc. will post 9.71 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.